Alexander Balck from the Institute of Neurogenetics and Department of Neurology received >340.000€ from the Else Kröner-Fresenius Foundation (https://www.ekfs.de/) to conduct a longitudinal investigation of epigenetic Modifiers of Parkinson's disease in the DeNoPa cohort (https://www.denopa.de/).